NCT02183948

Brief Summary

The purpose is to test whether oxytocin has an effect on masked facial expressions

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Jun 2014

Shorter than P25 for early_phase_1

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

June 30, 2014

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 8, 2014

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

March 7, 2017

Status Verified

March 1, 2017

Enrollment Period

6 months

First QC Date

June 30, 2014

Last Update Submit

March 4, 2017

Conditions

Facial Expressions

Keywords

treatmentmask face exoressionsgenier

Outcome Measures

Primary Outcomes (1)

  • Number of participants with neuro activity to facial expressions

    one week

Study Arms (2)

oxytocin

EXPERIMENTAL

nasal spray

Drug: Oxytocin

Placebo

PLACEBO COMPARATOR

nasal spray

Drug: Placebo

Interventions

OxytocinDRUG
oxytocin
PlaceboDRUG
Placebo

Eligibility Criteria

Age18 Years - 29 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy subjects, no smoke or drink alcohol, coffee or other stimulants during the day before Experiment.

You may not qualify if:

  • history of head injury; pregnancy; uterine cavity operations were took within one year; medical or psychiatric illness; rhinitis in case they may not fully absorb the spray.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Facial Expression

Interventions

Oxytocin

Condition Hierarchy (Ancestors)

Nonverbal CommunicationCommunicationBehavior

Intervention Hierarchy (Ancestors)

Pituitary Hormones, PosteriorPituitary HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPeptidesAmino Acids, Peptides, and Proteins

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor / Research group leader

Study Record Dates

First Submitted

June 30, 2014

First Posted

July 8, 2014

Study Start

June 1, 2014

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

March 7, 2017

Record last verified: 2017-03